[HTML][HTML] Autoantibodies in Alzheimer's disease: potential biomarkers, pathogenic roles, and therapeutic implications
J Wu, L Li - Journal of biomedical research, 2016 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is a prevalent and debilitating neurodegenerative disorder in the
elderly. The etiology of AD has not been fully defined and currently there is no cure for this …
elderly. The etiology of AD has not been fully defined and currently there is no cure for this …
[PDF][PDF] The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine
E Leclerc, CW Heizmann - Front Biosci (Schol Ed), 2011 - article.imrpress.com
Introduction 3. General features of S100 proteins 4. The receptor for advanced glycation
endproducts (RAGE) 5. Structures and functions of S100 proteins and RAGE: association …
endproducts (RAGE) 5. Structures and functions of S100 proteins and RAGE: association …
Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis
MK Chatanaka, D Sohaei, EP Diamandis… - Critical Reviews in …, 2023 - Taylor & Francis
The amyloid hypothesis has so far been at the forefront of explaining the pathogenesis of
Alzheimer's Disease (AD), a progressive neurodegenerative disorder that leads to cognitive …
Alzheimer's Disease (AD), a progressive neurodegenerative disorder that leads to cognitive …
Platelet immunoglobulin and amyloid precursor protein as potential peripheral biomarkers for Alzheimer's disease: findings from a pilot study
EB Mukaetova-Ladinska, Z Abdel-All, S Dodds… - Age and …, 2012 - academic.oup.com
Background: the diagnosis of dementia, in particular Alzheimer's disease (AD), is enhanced
with the use of molecular biomarkers. Since cerebrospinal fluid analysis and molecular …
with the use of molecular biomarkers. Since cerebrospinal fluid analysis and molecular …
Blood and cerebrospinal fluid autoantibody to Aβ levels in patients with Alzheimer's disease: A meta-analysis study
XW Li, XX Li, QS Liu, Y Cheng - Journal of Molecular Neuroscience, 2020 - Springer
Autoantibodies to beta amyloid (Aβ) have been suggested to be involved in the
pathogenesis of Alzheimer's disease (AD). However, data from clinical studies were …
pathogenesis of Alzheimer's disease (AD). However, data from clinical studies were …
Neurobiology of nAChRs and cognition: A mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career
AV Terry Jr, MW Decker - Biochemical pharmacology, 2011 - Elsevier
This review highlights some of the many contributions of the late Dr. Jerry J. Buccafusco to
the neurobiology of nicotinic acetylcholine receptors (nAChRs) and cognition over a 25 year …
the neurobiology of nicotinic acetylcholine receptors (nAChRs) and cognition over a 25 year …
Increase in Platelet Immunoglobulin in Alzheimer's Disease is Normalised Following Cholinesterase Inhibitor Treatment: Preliminary Results
EB Mukaetova-Ladinska, Z Abdel-All… - Journal of …, 2012 - content.iospress.com
Abstract We report a 16.5% increase in platelet immunoglobulin (Ig) content in subjects with
Alzheimer's disease (AD) in relation to cognitively intact individuals (p= 0.021), whereas the …
Alzheimer's disease (AD) in relation to cognitively intact individuals (p= 0.021), whereas the …
Vývoj MELISA metody pro stanovení autoprotilátek spojených s Alzheimerovou chorobou
V Vozandychová - 2017 - dk.upce.cz
Diplomová práce se zabývá optimalizací metody ELISA na magnetických částicích pro
stanovení autoprotilátek ze séra proti biomarkeru Alzheimerovy choroby, amyloidu beta (1 …
stanovení autoprotilátek ze séra proti biomarkeru Alzheimerovy choroby, amyloidu beta (1 …
Intérêt du RAGE comme biomarqueur circulant: du sRAGE aux autoanticorps anti-sRAGE
R Lorenzi - 2013 - theses.hal.science
Les pathologies cardio-vasculaires (CVD) représentent la principale cause de morbidité et
demortalité dans le monde. Le risque de CVD augmente avec l'âge, le tabagisme, le …
demortalité dans le monde. Le risque de CVD augmente avec l'âge, le tabagisme, le …